Abstract: A system SY for determining a tissue type TY of a tissue region TR is provided in which the distal ends OFDE1 . . . n of at least three optical fibers define a plurality of intersecting optical paths IOP1 . . . k within the tissue region TR. A tissue signal Q1 . . . k indicative of a tissue type TY for the respective optical path IOP1 . . . k is generated from said spectral measurement data SMD corresponding to each of the plurality of intersecting optical paths IOP1 . . . k. Each tissue signal Q1 . . . k is compared with a reference threshold QRT for the tissue type, and with an average of the tissue signals QMA. At least a portion of the tissue region is identified as the tissue type TY if i) every tissue signal Q1 . . . k in the tissue region TR indicates that its corresponding tissue is not the tissue type TY in the comparison with the N reference threshold QRT and ii) at least one of the tissue signals Q1 . . . k in the tissue region TR lies between the average QMA of the tissue signals Q1 . . .

Abstract: The present invention relates to a monitoring apparatus (101) for monitoring an ablation procedure. The monitoring apparatus (101) comprises an ultrasound signal providing unit for providing an ultrasound signal that depends on received echo series of an object (4) that is ablated. The monitoring apparatus (101) further comprises an ablation depth determination unit (103) for determining an ablation depth from the provided ultrasound signal. The ablation depth can be determined directly from the ultrasound signal and is an important parameter while performing an ablation procedure. For example, it can be used for determining the progress of ablation within the object (4) and for determining when the ablation has reached a desired progression.

Abstract: The invention relates to a method of determining in vitro the amount of nuclear DNA within a human or animal cell using UV absorption measurement with UV light. The invention also relates to a method for detecting in vitro cancerous cells in a biological sample relying on the aforementioned principles. The invention also relates to an in vitro method of diagnosing or predicting the likely occurrence of cancer in a human or animal subject.

Abstract: The invention relates to an ingestible capsule and method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being.

Abstract: The invention relates to an ingestible capsule and method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being.

Abstract: The application relates to an ingestible capsule and method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being.

Abstract: A catheter apparatus includes an elongated body having proximal and distal ends, and an acoustic transducer disposed proximate the distal end of the elongated body. A variably-refracting acoustic lens is provided to dynamically adjust a direction associated with an acoustic wave coupled to the acoustic transducer in response to one or more control signals provided thereto.

Abstract: The present invention relates to a monitoring apparatus (101) for monitoring an ablation procedure. The monitoring apparatus (101) comprises an ultrasound signal providing unit for providing an ultrasound signal that depends on received echo series of an object (4) that is ablated. The monitoring apparatus (101) further comprises an ablation depth determination unit (103) for determining an ablation depth from the provided ultrasound signal. The ablation depth can be determined directly from the ultrasound signal and is an important parameter while performing an ablation procedure. For example, it can be used for determining the progress of ablation within the object (4) and for determining when the ablation has reached a desired progression.

Abstract: A display panel includes pixels with a light emissive layer and an electrode layer deposited on the light emissive layer. A first pixel is determined by a first barrier structure and a second pixel, adjacent to the first pixel, is determined by a second barrier structure. The first and second barrier structures are separated by an electrically conductive structure in electrical contact with the electrode layer. Accordingly, space is available between the barrier structures for electrical shunting of the electrode layer.

Abstract: A catheter apparatus (100, 2000, 3000, 4000, 540) includes an elongated body (110) having proximal (112) and distal (114) ends, an acoustic transducer (130, 2300, 5 3300, 4300, 544), disposed proximate the distal end (114) of the elongated body (110), and a variably-refracting acoustic lens (140, 2200, 3200, 4200, 542) adapted to dynamically adjust a direction associated with an acoustic wave coupled to the acoustic transducer in response to one or more control signals provided thereto.

Abstract: A system is provided that may be used for locating and diagnosing lesions in the human body in vivo. In some embodiments, once the exact position of a lesion is found, a biopsy may be taken from the lesion using e.g. ultra sound techniques for guidance of the biopsy needle. Use of the system drastically reduces the negative biopsy samples compared to currently used “blind sampling” techniques. This reduces patient discomfort and minimizes infections as the number of biopsy samples is reduced. A method and computer-readable medium is also provided.

Abstract: A system for imaging of prostate cancer in a prostate in vivo is provided. The system utilizes Diffuse Optical Tomography (DOT) for creating a 3D image for the detection of suspicious prostate tissue. The DOT image may be used to guide the biopsy, thereby reducing the number of false negatives. A method, computer-readable medium and use are also provided.

Abstract: The invention relates to a method of determining in vivo in a human or animal subject the amount of nuclear DNA by first localizing cell nuclei of living tissue and subsequently measuring the nuclear UV absorbance using confocal scanning microscopy. The invention relates also to a method for detecting cancerous cells in vivo in a human or animal subject by first identifying the localization of cell nuclei in living tissue and subsequently determining the nuclear UV absorbance by laser scanning confocal microscopy. Furthermore, the invention relates to a method of diagnosing cancer in a human or animal subject in vivo relying on a combination of identifying the localization of cell nuclei in living tissue and measuring nuclear UV absorbance by laser scanning confocal microscopy.

Abstract: In a medical therapy or diagnostic system, magnetic resonance (MR) techniques are used in order to determine the position of the focal point of an ultrasound wave with respect to a patient's body. Therefore, it is an object of the present invention to provide an ultrasound waveguide which could be used within a magnetic resonance environment. To better address these concerns, it is an aspect of the present invention to provide an ultrasound waveguide comprising an electrically conducting section and an electrically isolating section. A reduction of the length of an electrically isolating section possibly decreases the electromagnetic coupling of the high frequency electromagnetic field in the MR environment to the electrically conducting section.

Abstract: The invention relates to a display panel (2) comprising a plurality of display pixels (3) with at least one light emissive layer (10) and at least one electrode layer (7) deposited on or over said light emissive layer. A first display pixel (3A) is determined by a first barrier structure (20) and a second display pixel (3B), adjacent to said first display pixel, is determined by a second barrier structure (21). The first barrier structure and second barrier structure are separated by an electrically conductive structure (22) in electrical contact with the electrode layer. Accordingly, space is available between the barrier structures (20,21) for electrical shunting of the electrode layer (7). The invention further relates to an electric device comprising such a display panel and a method for manufacturing a display panel.

Abstract: A display panel is formed on a substrate and includes display pixels with at least one light emissive layer and at least one electrode layer or cathode deposited on or over said light emissive layer. The display panel further includes electrically conductive structures shunting the electrode layer. The barrier structures separating the display pixels may be used as the electrically conductive structures.

Abstract: The invention relates to a method of determining in vitro the amount of nuclear DNA within a human or animal cell using UV absorption measurement with UV light. The invention also relates to a method for detecting in vitro cancerous cells in a biological sample relying on the aforementioned principles. The invention also relates to an in vitro method of diagnosing or predicting the likely occurrence of cancer in a human or animal subject.

Abstract: The application relates to an ingestible capsule and method for in vivo imaging and/or treatment of one or more diseased areas of interest within the gastrointestinal tract of an animal or human being.

Abstract: A method of displaying an input signal (IV) on a full color LED display is discussed wherein the display has pixels (11) comprising at least four LED's (PLi) which respectively emit light with four primary colors. The method comprises converting (SC) the input signal (IV) into drive signals for the at least four LED's (PLi). The converting (SC) comprises: (i) determining (RD) valid ranges (VRi) of at least two of the drive signals (DSi) to obtain a color of the combined light emitted which fits the input signal (IV), (ii) determining (LD) a gradation or lifetime indication (LTi) of the at least two LED's (PLi) for associated ones of the drive signals (DSi) within the valid ranges (VRi), and (iii) determining (CD) a combination (DCi) of values of drive signals (DSi) providing substantially the minimum degradation, or the maximum lifetime, of a combination of the at least two LED's (PLi) based on the degradation or lifetime indications (LTi).

Abstract: The invention relates to a vacuum display device comprising a display screen (30) having picture elements (35), cathode means (20) for generating a plurality of electron beams (EB), each corresponding to one of the picture elements (35), and addressing means (41,42) for addressing the picture element (35) through modulation of the intensity of an electron beam corresponding to the picture element (35). A channel structure (10) is arranged adjacent the cathode means (20). The channel structure (10) comprises a plurality of electron beam guidance cavities (15), each corresponding to one of the picture elements (35), and protects the cathode means (20) from incident ions. The exit (17) of the cavity (15) is smaller than the entrance (16), so that an electron beam (EB) exiting from the cavity (15) has a particularly high brightness and spatial uniformity.